Itau Unibanco Holding S.A. increased its stake in shares of Express Scripts Holding (NASDAQ:ESRX) by 262.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 8,960 shares of the company’s stock after buying an additional 6,487 shares during the quarter. Itau Unibanco Holding S.A.’s holdings in Express Scripts were worth $669,000 as of its most recent SEC filing.
Several other hedge funds also recently bought and sold shares of ESRX. SeaCrest Wealth Management LLC acquired a new stake in Express Scripts in the fourth quarter valued at approximately $105,000. Bank of Nova Scotia Trust Co. acquired a new stake in Express Scripts in the third quarter valued at approximately $120,000. Monroe Bank & Trust MI lifted its stake in Express Scripts by 74.8% in the third quarter. Monroe Bank & Trust MI now owns 2,266 shares of the company’s stock valued at $156,000 after acquiring an additional 970 shares during the last quarter. Harvest Fund Management Co. Ltd acquired a new stake in Express Scripts in the fourth quarter valued at approximately $183,000. Finally, Nelson Roberts Investment Advisors LLC acquired a new stake in Express Scripts in the third quarter valued at approximately $193,000. Institutional investors and hedge funds own 86.45% of the company’s stock.
In related news, VP Christine Houston sold 10,104 shares of the business’s stock in a transaction on Friday, December 15th. The shares were sold at an average price of $70.08, for a total transaction of $708,088.32. Following the transaction, the vice president now owns 87,400 shares of the company’s stock, valued at $6,124,992. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Glen D. Stettin sold 3,449 shares of the business’s stock in a transaction on Thursday, January 11th. The stock was sold at an average price of $81.00, for a total transaction of $279,369.00. Following the transaction, the vice president now directly owns 33,715 shares in the company, valued at approximately $2,730,915. The disclosure for this sale can be found here. Insiders have sold 17,001 shares of company stock worth $1,249,505 in the last ninety days. 0.68% of the stock is currently owned by insiders.
ESRX has been the subject of a number of analyst reports. Maxim Group lifted their target price on shares of Express Scripts from $78.00 to $87.00 and gave the company a “buy” rating in a research note on Thursday, December 14th. Deutsche Bank began coverage on shares of Express Scripts in a research report on Monday, December 4th. They issued a “buy” rating and a $75.00 price target on the stock. Zacks Investment Research lowered shares of Express Scripts from a “buy” rating to a “sell” rating in a research report on Tuesday, October 24th. Royal Bank of Canada set a $66.00 price target on shares of Express Scripts and gave the company a “hold” rating in a research report on Wednesday, October 25th. Finally, SunTrust Banks set a $86.00 price target on shares of Express Scripts and gave the company a “buy” rating in a research report on Thursday, December 21st. Five equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $78.93.
Express Scripts Holding (ESRX) opened at $75.23 on Tuesday. Express Scripts Holding has a 52-week low of $55.80 and a 52-week high of $83.49. The company has a market cap of $42,608.24, a P/E ratio of 11.00, a PEG ratio of 0.81 and a beta of 0.93. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.73 and a quick ratio of 0.61.
Express Scripts declared that its Board of Directors has initiated a share buyback program on Monday, December 18th that authorizes the company to buyback 45,000,000 outstanding shares. This buyback authorization authorizes the company to buy shares of its stock through open market purchases. Shares buyback programs are typically a sign that the company’s management believes its stock is undervalued.
Express Scripts Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.